semaglutide cardiac effects Variable weight-loss and cardiovascular benefits were seen with GLP-1 drugs in a systematic review and network meta-analysis, but on quality of life were less clear. https://www.medpagetoday.com/primarycare/obesity/122142 The Cardioprotective Effects of Semaglutide

Week 17 and beyond: 2.4 mg once weekly

Recent animal- and human-based studies described the enhanced percentage of eryptotic erythrocytes in patients with hepatic failure and hyperbilirubinemia [210, 250, 280, 283, 284]

Cost: GLP-1 receptor agonists can be expensive compared to traditional diabetes medications

These issues can negatively impact patient satisfaction, treatment adherence, and healthcare provider confidence in prescribing these drugs

European J of Heart Fail 15(9):9951002 Forslund T, Kosidou K, Wicks S, Dalman C (2020) Trends in psychiatric diagnoses, medications and psychological therapies in a large Swedish region: a population-based study

It is also licensed for adolescents aged 12 years and older with body weight above 60 kg and BMI equivalent to 30 kg/m